Lark, founded in 2011, is a healthcare technology company specializing in AI-driven personalized health coaching. Lark’s platform aims to manage and improve chronic conditions like diabetes and hypertension through automated, real-time coaching. Targeting healthcare providers and insurers, Lark is striving to create cost-effective and scalable solutions. Lark is headquartered in Mountain View, California.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/13/2021 | Series D | $100MM | $xx.xx | $788.69MM | Castlepeak, Deerfield Management Company, Franklin Templeton, Ipd, King River Capital, Olive Tree Capital, Pfm Health Sciences, Weili Dai | |
Price per Share
$xx.xx
Shares Outstanding
6,483,360
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Castlepeak, Deerfield Management Company, Franklin Templeton, Ipd, King River Capital, Olive Tree Capital, Pfm Health Sciences, Weili Dai
|
||||||
10/08/2020 | Series C | $55.88MM | $xx.xx | $241.38MM | Asset Management Ventures, Dr. Jonathan Fielding, Franklin Templeton, King River Capital, Lightspeed Ventures, Olive Tree Capital, Steelsky Ventures, Weili Dai | |
Price per Share
$xx.xx
Shares Outstanding
9,919,600
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Asset Management Ventures, Dr. Jonathan Fielding, Franklin Templeton, King River Capital, Lightspeed Ventures, Olive Tree Capital, Steelsky Ventures, Weili Dai
|
||||||
06/01/2017 | Series B | $20.14MM | $xx.xx | $99.01MM | Asset Management Ventures, Dr. Jonathan Fielding, Lightspeed Ventures, Weili Dai | |
Price per Share
$xx.xx
Shares Outstanding
6,079,163
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Asset Management Ventures, Dr. Jonathan Fielding, Lightspeed Ventures, Weili Dai
|
||||||
04/13/2013 | Series A-1 | $1.44MM | $xx.xx | $34.51MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,610,717
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/13/2013 | Series A | $7.03MM | $xx.xx | $34.51MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,276,635
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/13/2013 | Series A-2 | $3.15MM | $xx.xx | $34.51MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,967,132
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|